Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ARTES Biotechnology GmbH logo — Microbial Cell Lines, Processes and Products for Today and T...

ARTES Biotechnology GmbH

Microbial Cell Lines, Processes and Products for Today and Tomorrow

Founded 2002 Germany Langenfeld, Germany 8 employees Biotechnology, Pharmaceutical

General Information

Company Name ARTES Biotechnology GmbH
Founded Year 2002
Location Germany Langenfeld, Germany +1
Employees 8
Industries Biotechnology, Pharmaceutical
Social

Get notified when ARTES Biotechnology GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ARTES Biotechnology GmbH

ARTES Biotechnology GmbH is a globally active R&D company that has been specializing in developing biopharmaceutical production processes since 2002. The company has positioned itself as a valuable partner for the pharmaceutical industry by offering proprietary expression systems and expertise from cell line development to manufacturing. They have successfully implemented several technology transfers worldwide at clients'​ sites. ARTES is a well-established partner for the development of customer-driven projects and has the capability to supply pre-clinical material. In addition, the company is also involved in developing its own virus-like particle (VLP) based vaccine candidates up to proof-of-concept in animals. Based in Germany, ARTES Biotechnology operates in the Biotechnology and Pharmaceutical industries. Currently, there is no publicly available information about their last investment or the investors involved.

Taxonomy: Biopharmaceutical Production Processes, Vaccine Development, Virus Like Particles, Cell Line Development, Recombinant Protein, Contract R&D, Upstream Development, Downstream Development, CDMO, Contract Development and Manufacturing Organization

No funding data available for ARTES Biotechnology GmbH yet.

Get notified when ARTES Biotechnology GmbH raises funding

ARTES Biotechnology GmbH Alternatives & Competitors

ARTES Biotechnology GmbH vs
Caspian Pharmaceuticals
Caspian Pharmaceuticals India

Quality Over Quantity

8 employees
Manufacturing, Pharmaceutical
ARTES Biotechnology GmbH vs
Lyrus
Lyrus India

Lyrus is a research and development (R&D) organisation doing contract drug development & manufacturi...

112 employees
Life Sciences, Manufacturing
ARTES Biotechnology GmbH vs
Exemplify Biopharma, Inc., a Symeres Company
Exemplify Biopharma, Inc., a Symeres Company United States

Advancing Drug Development with CMC Consulting and Laboratory Expertise, All Under One Roof

19 employees
Analytics, Biopharma

FAQ About ARTES Biotechnology GmbH

Microbial Cell Lines, Processes and Products for Today and Tomorrow
ARTES Biotechnology GmbH was founded in 2002.
ARTES Biotechnology GmbH is headquartered in Langenfeld, Germany.
ARTES Biotechnology GmbH operates in the following industries: Biotechnology, Pharmaceutical.
ARTES Biotechnology GmbH has approximately 8 employees.
Top alternatives and competitors to ARTES Biotechnology GmbH include Caspian Pharmaceuticals, Lyrus, Exemplify Biopharma, Inc., a Symeres Company, Cloverty, iQure Pharma Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ARTES Biotechnology GmbH and Caspian Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ARTES Biotechnology GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes